Gedeon, Patrick C <br/><br/>
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  08 2018 
 - 3611-3631 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-17-0126  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Bispecific--pharmacology<br/>CD3 Complex--antagonists & inhibitors<br/>Cell Line, Tumor<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Gene Expression Regulation, Neoplastic--immunology<br/>Glioma--drug therapy<br/>Humans<br/>Immunotherapy<br/>Lymphocyte Activation--drug effects<br/>Male<br/>Mice<br/>Recombinant Proteins--genetics<br/>Single-Chain Antibodies--immunology<br/>T-Lymphocytes--drug effects<br/>Xenograft Model Antitumor Assays